Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagno...
Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
About this item
Full title
Author / Creator
DeAngelo, D J , Stevenson, K E , Dahlberg, S E , Silverman, L B , Couban, S , Supko, J G , Amrein, P C , Ballen, K K , Seftel, M D , Turner, A R , Leber, B , Howson-Jan, K , Kelly, K , Cohen, S , Matthews, J H , Savoie, L , Wadleigh, M , Sirulnik, L A , Galinsky, I , Neuberg, D S , Sallan, S E and Stone, R M
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
On the basis of the data suggesting that adolescents and young adult patients with acute lymphoblastic leukemia (ALL) have improved outcomes when treated on pediatric protocols, we assessed the feasibility of treating adult patients aged 18–50 years with ALL with the DFCI Pediatric ALL Consortium regimen utilizing a 30-week course of pharmacokineti...
Alternative Titles
Full title
Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4360211
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4360211
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2014.229
